Osaic Holdings
NGNE icon

Osaic Holdings’s Neurogene NGNE Stock Holding History

Osaic Holdings’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-60
Closed -$702 – 7832
2025
Q1 		$702 Sell
60
-77
-56% -$1.34K ﹤0.01% 6915
2024
Q4 		$3.13K Buy
137
+107
+357% +$3.98K ﹤0.01% 6429
2024
Q3 		$1.26K Hold
30
– – ﹤0.01% 6766
2024
Q2 		$1.09K Buy
+30
New +$1.06K ﹤0.01% 6795
2024
Q1 		– Sell
-25
Closed -$485 – 7333
2023
Q4 		$485 Hold
25
– – ﹤0.01% 6897
2023
Q3 		$395 Sell
25
-50
-67% -$738 ﹤0.01% 7034
2023
Q2 		$1.25K Hold
75
– – ﹤0.01% 6813
2023
Q1 		$1.08K Hold
75
– – ﹤0.01% 6926
2022
Q4 		$1K Hold
75
– – ﹤0.01% 6912
2022
Q3 		$1K Sell
75
-38
-34% -$776 ﹤0.01% 7022
2022
Q2 		$2K Buy
113
+38
+51% +$927 ﹤0.01% 6906
2022
Q1 		$3.39M Hold
75
– – 0.01% 1498
2021
Q4 		$7K Hold
75
– – ﹤0.01% 6478
2021
Q3 		$11K Buy
75
+25
+50% +$3.83K ﹤0.01% 6149
2021
Q2 		$10K Hold
50
– – ﹤0.01% 6070
2021
Q1 		$13K Sell
50
-10
-17% -$2.56K ﹤0.01% 5739
2020
Q4 		$17K Buy
+60
New +$14.7K ﹤0.01% 5255

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Osaic Holdings's NGNE Position: Q2 2025 in Review

Osaic Holdings sold out of Neurogene (NGNE) in Q2 2025, closing a stake of 60 shares — an estimated $702 sold.

Osaic Holdings first reported a position in NGNE in Q4 2020 and held it in 17 quarters. The position peaked at $3.39M in Q1 2022. 82 funds tracked by Wall St. Rank hold NGNE as of Q2 2025.

  • Osaic Holdings reported no remaining Neurogene position as of Q2 2025 after selling out during the quarter.
  • Osaic Holdings sold 60 Neurogene shares in Q2 2025, an estimated $702.
  • Osaic Holdings first reported a position in Neurogene in Q4 2020 and held it in 17 quarters.
  • Osaic Holdings's Neurogene position peaked at $3.39M in Q1 2022.
  • 82 funds tracked by Wall St. Rank held Neurogene as of Q2 2025.

Based on Osaic Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.